Cargando…
A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: synthesis and preclinical characterization of [(18)F]SDM-16
PURPOSE: To quantify the synaptic vesicle glycoprotein 2A (SV2A) changes in the whole central nervous system (CNS) under pathophysiological conditions, a high affinity SV2A PET radiotracer with improved in vivo stability is desirable to minimize the potential confounding effect of radiometabolites....
Autores principales: | Zheng, Chao, Holden, Daniel, Zheng, Ming-Qiang, Pracitto, Richard, Wilcox, Kyle C., Lindemann, Marcel, Felchner, Zachary, Zhang, Li, Tong, Jie, Fowles, Krista, Finnema, Sjoerd J., Nabulsi, Nabeel, Carson, Richard E., Huang, Yiyun, Cai, Zhengxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940841/ https://www.ncbi.nlm.nih.gov/pubmed/34761284 http://dx.doi.org/10.1007/s00259-021-05597-5 |
Ejemplares similares
-
Further Investigation of Synaptic Vesicle Protein
2A (SV2A) Ligands Designed for Positron Emission Tomography and Single-Photon
Emission Computed Tomography Imaging: Synthesis and Structure–Activity
Relationship of Substituted Pyridinylmethyl-4-(3,5-difluorophenyl)pyrrolidin-2-ones
por: Pracitto, Richard, et al.
Publicado: (2021) -
Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging
por: Matuskey, David, et al.
Publicado: (2020) -
Decreased synaptic vesicle glycoprotein 2A binding in a rodent model of familial Alzheimer's disease detected by [(18)F]SDM-16
por: Zheng, Chao, et al.
Publicado: (2023) -
Feasibility of imaging synaptic density in the human spinal cord using [(11)C]UCB-J PET
por: Rossano, Samantha, et al.
Publicado: (2022) -
Imaging the effect of ketamine on synaptic density (SV2A) in the living brain
por: Holmes, Sophie E, et al.
Publicado: (2022)